Shares of Healius (ASX:HLS) surged 11.8% on March 27, reaching A$1.465. This rise was driven by positive financial updates, including a 6.2% year-to-date revenue increase and a 4% jump in volumes for the company’s February results. If these gains hold, Healius is set to …

Australian energy stocks, represented by the sector index .AXEJ, experienced a third consecutive day of gains on March 27, rising as much as 1.13%. This boost in energy shares comes amid concerns over tightening global oil supply, particularly following a U.S. tariff threat targeting …

Australian shares faced a setback on Thursday, March 27, with the S&P/ASX 200 index (.AXJO) dropping 0.6% to 7,950.6. This marks a pause in the index’s five-day rally as concerns about trade tensions and weakness in the financial sector weighed on market sentiment. The …

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, has announced the completion of clinical evaluations for the last patient in its ATH434-202 Phase 2 trial. This open-label study is designed to assess the safety, efficacy, …